162 related articles for article (PubMed ID: 11910748)
21. [Telomerase inhibitor].
Ide T
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1600-5. PubMed ID: 9309160
[TBL] [Abstract][Full Text] [Related]
22. Telomere shortening in human HL60 cells by treatment with 3'-azido-2',3'-dideoxynucleosides and telomerase inhibition by their 5'-triphosphates.
Liu X; Inomata M; Ogawara T; Saneyoshi M; Yamaguchi T
Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1067-71. PubMed ID: 18058538
[TBL] [Abstract][Full Text] [Related]
23. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics.
Seimiya H; Muramatsu Y; Ohishi T; Tsuruo T
Cancer Cell; 2005 Jan; 7(1):25-37. PubMed ID: 15652747
[TBL] [Abstract][Full Text] [Related]
24. [Progress on telomere and telomerase].
Yang X; Tao M
Wei Sheng Yan Jiu; 2004 May; 33(3):369-71. PubMed ID: 15211818
[TBL] [Abstract][Full Text] [Related]
25. [Molecular mechanisms involved in the regulation of telomerase activity].
Liu WJ; Ding J
Sheng Li Ke Xue Jin Zhan; 2001 Jul; 32(3):220-4. PubMed ID: 12545793
[TBL] [Abstract][Full Text] [Related]
26. The structure and function of telomerase reverse transcriptase.
Autexier C; Lue NF
Annu Rev Biochem; 2006; 75():493-517. PubMed ID: 16756500
[TBL] [Abstract][Full Text] [Related]
27. Telomerase regulation and progressive telomere shortening of rat hepatic stem-like epithelial cells during in vitro aging.
Oh BK; Lee CH; Park C; Park YN
Exp Cell Res; 2004 Aug; 298(2):445-54. PubMed ID: 15265692
[TBL] [Abstract][Full Text] [Related]
28. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
29. Role of telomerase in hematopoietic stem cells.
Lansdorp PM
Ann N Y Acad Sci; 2005 Jun; 1044():220-7. PubMed ID: 15958715
[TBL] [Abstract][Full Text] [Related]
30. Telomerase inhibition is a specific early event in salvicine-treated human lung adenocarcinoma A549 cells.
Liu WJ; Zhang YW; Shen Y; Jiang JF; Miao ZH; Ding J
Biochem Biophys Res Commun; 2004 Oct; 323(2):660-7. PubMed ID: 15369801
[TBL] [Abstract][Full Text] [Related]
31. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells.
Chen Z; Koeneman KS; Corey DR
Cancer Res; 2003 Sep; 63(18):5917-25. PubMed ID: 14522918
[TBL] [Abstract][Full Text] [Related]
32. Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase.
Nowak T; Januszkiewicz D; Zawada M; Pernak M; Lewandowski K; Rembowska J; Nowicka K; Mankowski P; Nowak J
Oncol Rep; 2006 Aug; 16(2):301-5. PubMed ID: 16820907
[TBL] [Abstract][Full Text] [Related]
33. Telomerase, senescence and ageing.
Shawi M; Autexier C
Mech Ageing Dev; 2008; 129(1-2):3-10. PubMed ID: 18215413
[TBL] [Abstract][Full Text] [Related]
34. Telomerase and cancer: revisiting the telomere hypothesis.
Autexier C; Greider CW
Trends Biochem Sci; 1996 Oct; 21(10):387-91. PubMed ID: 8918193
[TBL] [Abstract][Full Text] [Related]
35. How telomerase reaches its end: mechanism of telomerase regulation by the telomeric complex.
Bianchi A; Shore D
Mol Cell; 2008 Jul; 31(2):153-65. PubMed ID: 18657499
[TBL] [Abstract][Full Text] [Related]
36. Telomere inhibition and telomere disruption as processes for drug targeting.
Rezler EM; Bearss DJ; Hurley LH
Annu Rev Pharmacol Toxicol; 2003; 43():359-79. PubMed ID: 12540745
[TBL] [Abstract][Full Text] [Related]
37. Induction of apoptosis and inhibition of telomerase activity in human bone marrow and HL-60 p53 null cells treated with anti-cancer drugs.
Malerba I; Gribaldo L; Diodovich C; Carloni M; Meschini R; Bowe G; Collotta A
Toxicol In Vitro; 2005 Jun; 19(4):523-32. PubMed ID: 15826810
[TBL] [Abstract][Full Text] [Related]
38. Telomerase inhibitors identified by a forward chemical genetics approach using a yeast strain with shortened telomere length.
Nakai R; Ishida H; Asai A; Ogawa H; Yamamoto Y; Kawasaki H; Akinaga S; Mizukami T; Yamashita Y
Chem Biol; 2006 Feb; 13(2):183-90. PubMed ID: 16492566
[TBL] [Abstract][Full Text] [Related]
39. Telomere maintenance in clinical medicine.
Ulaner GA
Am J Med; 2004 Aug; 117(4):262-9. PubMed ID: 15308436
[TBL] [Abstract][Full Text] [Related]
40. Telomerase inhibition by 3'-azido-2', 3'-dideoxynucleoside 5'-triphosphates and telomere shortening in human cultured cells by the corresponding nucleosides.
Yamaguchi T; Liu X; Ogawara T; Inomata M; Saneyoshi M
Nucleic Acids Symp Ser (Oxf); 2006; (50):271-2. PubMed ID: 17150922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]